ArticleCureus2025
Bilateral Ovarian Steroid Cell Tumor With One-Year Disease-Free Follow-Up: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ovarian steroid cell tumors are rare sex cord-stromal neoplasms that may produce androgens and present with nonspecific gynecologic symptoms. Bilateral involvement is particularly uncommon and raises important diagnostic and therapeutic challenges in young women. We describe the case of a 25-year-old woman with bilateral adnexal masses who was evaluated with cross-sectional imaging and surgery, leading to the diagnosis of an ovarian steroid cell tumor. Definitive management was planned in a multidisciplinary setting and included surgical resection, adjuvant systemic treatment, and structured clinical, biochemical, and radiologic surveillance. The patient has remained disease-free on follow-up. This case underscores the importance of considering steroid cell tumor in the differential diagnosis of solid ovarian masses in reproductive-age patients, the central role of histopathology and immunohistochemistry in confirming the diagnosis, and the need to balance oncologic safety with fertility and endocrine considerations in young women with rare ovarian tumors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.